Reach the clinicians, hospital executives, and reporters who decide which healthcare AI products earn trust and adoption.
Healthcare AI is sold to skeptical buyers in a slow-moving, evidence-driven market. We help you show up with the clinical credibility, named-system stories, and earned media that actually move the deal.
The State of AI Healthcare Marketing
Healthcare AI is one of the harder marketing challenges in technology. Your buyers are clinicians, hospital executives, payers, and pharma decision-makers, all of whom evaluate vendors against real outcomes data, regulatory posture, and named-system case studies. The marketing pattern that works for an agent or dev tools company does not translate. Capability claims without clinical evidence stall out before the first call.
Marketing a healthcare AI company in 2026 means showing up with the right kind of credibility for each audience: peer-reviewed validation for clinicians, deployment outcomes and EHR integration for IT leaders, regulatory and reimbursement clarity for compliance and finance, and a clear story for the executive sponsor who has to defend the investment to a board. Different launches lean on different channels. A new clinical study often calls for press placement to land first; a deployment milestone or a clinician-creator video can run on its own.
What Most Agencies Miss
These are the issues that come up every time we plan a campaign in this vertical, regardless of company stage.
Buyers in this category have been burned by healthcare AI hype before. A clear capability claim without peer-reviewed validation, real-world performance data, or a credible regulatory pathway rarely survives the first eval call. The marketing job is to make the evidence the story, not to dress up the capability.
A typical health system deal involves a Chief Medical Information Officer, a Chief Information Officer, the clinicians who will use the tool, an IT security review, a HIPAA and BAA review, a value-analysis committee, procurement, and sometimes the board. Marketing has to land messages that work for each of those audiences without diluting the clinical story.
A deployment story at Mass General, Cleveland Clinic, or Mayo, or a podium moment at HIMSS or RSNA, often shapes the next quarter of pipeline more than any single press hit. The campaign mix has to coordinate around those moments rather than treat them as one-off announcements.
Clinicians do not trust vendor marketing. They trust other clinicians. The tools that get adopted are usually championed by a respected practitioner who has used them, validated them, and recommended them in a peer-facing forum. Marketing has to enable that voice, not replace it.
Who Actually Buys
Who signs the check, who has veto power, what they care about, and what kills the deal.
Decision maker
The person who signs off
At health systems, the Chief Medical Information Officer (CMIO) or Chief Medical Officer (CMO) usually leads the decision, often with the CIO and a Chief AI Officer where the role exists. At pharma and biotech, a VP of Digital, Chief Digital Officer, or CTO signs off. At payers, the Chief Innovation Officer or VP of Health Services. In every case the deal needs C-suite or board ratification at scale.
Who else gets a vote
Practicing clinicians who will actually use the tool, IT and security teams reviewing data handling and EHR integration, compliance teams confirming HIPAA and HITRUST posture, legal reviewing the BAA, procurement and value-analysis committees, and at least one experienced clinician-skeptic who has watched a previous AI product fail in production.
What they care about
Peer-reviewed clinical validation, real-world deployment outcomes at named systems, FDA status (510(k), De Novo, or breakthrough designation where relevant), HIPAA and HITRUST posture, EHR integration (Epic, Oracle Health, Athenahealth), reimbursement and billing implications, malpractice and liability coverage, change-management support, and the long-term viability of the company.
What kills a deal
Thin or missing clinical evidence, an unclear or absent regulatory pathway when one is required, weak HIPAA posture, no plan for EHR integration, marketing claims that disagree with the validation data, and a story that ignores reimbursement or clinician workflow. Healthcare buyers walk away from any of these very quickly.
What We Do
Run one or both. Every engagement is flexible and month-to-month, no lock-ins, no wasted budget. Click into either service to see exactly how we run it.
Walkthroughs, reviews, and reaction content from technical creators who already reach healthcare AI buyers. We source, brief, contract, and report.
Coverage in TechCrunch, Forbes, Business Insider, VentureBeat, and the niche outlets your healthcare AI buyers read. Funding, launches, thought leadership.
Channel Mix
Many engagements run just one channel: influencers to amplify a specific launch video, PR for a funding announcement. When an engagement covers both, this is the split we typically use for healthcare AI companies.
Influencer
35%
PR
65%
Influencer
Clinician voices on LinkedIn and X, and physician-creators on YouTube, are how peer trust gets built in this category. A respected clinician walking through a real-world deployment, or a CMIO writing about an adoption decision, often opens more doors than any press hit on its own.
PR
Coverage in Stat News, Healthcare IT News, and Modern Healthcare establishes credibility with the clinical and executive audiences. Regulatory milestones, validation studies, and named-system deployments are stories that carry weight when reported by trusted healthcare press, much more than when announced by the vendor alone.
Press Targets
Real publications and the specific beats we pitch into. We do not mass-blast. Every angle is built for a named reporter.
Tier 1 priorities
Stat News
Health tech / clinical AI
The leading independent publication on health and life sciences. Stat sets the agenda for how clinical AI is understood by physicians, payers, and policymakers, and a feature here moves real procurement conversations.
Healthcare IT News
Health system technology adoption
The most-read trade publication for hospital IT leaders, CIOs, and CMIOs. A piece here lands directly with the buying audience at health systems and is forwarded inside hospital procurement teams.
Modern Healthcare
Health system business and policy
Reaches the executive readership at hospitals, payer organizations, and health policy. Coverage here gives a healthcare AI company air cover with C-suite buyers and trustees.
Also placing in
MedCity News
Health tech and digital health
Strong for funding announcements, deployment milestones, and category-defining product launches in digital health. Useful as a paired outlet alongside a tier-1 healthcare placement.
Becker's Health IT
Hospital IT leadership
Reaches CIOs, CMIOs, and IT leadership at hospital systems. Coverage in Becker's lands in inboxes during the annual budget and procurement cycle.
Fierce Healthcare
Health system and payer news
Trade publication read by health-system executives, payer leadership, and value-based care leaders. Useful for adoption and outcomes stories at scale.
The Wall Street Journal
Health and pharma
When a healthcare AI moment crosses into mainstream business news, WSJ is the outlet that reaches the broader investor and executive audience and triggers downstream board-level conversations.
Wired
AI / Big Story / health
Strong for narrative pieces that pair clinical capability with the human and policy story. A Wired feature builds long-running brand equity in a category where trust is the core asset.
Creator Archetypes
Each archetype converts a different stage of the buying journey. We build the campaign mix from the ones that fit your stage and ICP.
Practicing physicians, nurses, or clinical informatics leaders writing about adoption decisions, real workflow changes, and outcomes from healthcare AI tools. Audience is the buying committee at health systems.
How we use them
Sponsored case study posts or paid newsletter features where the clinician walks through a real deployment, including what worked and what required change management. Slower-converting but moves enterprise health-system pipeline more reliably than any other channel.
X
Physicians and researchers who post about new tools, peer-reviewed studies, FDA actions, and category trends. Audience is other clinicians, AI-in-medicine researchers, and informed policy voices.
How we use them
Pre-briefed access to validation data or a clinical pilot, paired with the methodology to support it. Buyers and other clinicians treat these voices as honest brokers, so a positive read here unlocks downstream conversations.
Podcast
Hosts of practitioner and policy podcasts focused on health tech, AI in medicine, and digital health. They book founders, clinicians, and executives shipping real systems.
How we use them
Founder, chief medical officer, or clinical lead interview as part of a broader narrative arc, often paired with a study release, FDA milestone, or named-system deployment.
YouTube
Practicing physicians who publish explainer videos, product reviews, and workflow walkthroughs aimed at peer clinicians and informed patients. Smaller in number than mainstream tech YouTubers but very high signal density.
How we use them
Long-form sponsorships where the physician uses the tool on a representative workflow on camera. Most effective when the creator has clinical relevance to the product and can speak to outcomes, not capabilities.
Story Angles That Work
Story shapes that tend to land in this vertical. Use them as a starting point. Every campaign gets a custom angle built around your actual proof.
"We deployed our model across [named health system] over 18 months and 50,000 patient encounters. Here is what changed in workflow, what changed in outcomes, and what we learned about the rollout."
Why it works. Real-world deployment stories at named systems are the single strongest story shape in healthcare AI press. Outcomes data plus rollout learnings earns coverage in Stat, Healthcare IT News, and Modern Healthcare at the same time.
"Our peer-reviewed validation in [journal] shows the model performs at parity with specialist clinicians on [endpoint]. Here is how the study was designed and what it does and does not say."
Why it works. Validation studies, treated as press moments rather than buried in the docs, drive credibility and inbound interest from health systems considering pilots.
"FDA breakthrough designation for [condition or workflow]: what it means for hospitals, payers, and patients."
Why it works. Regulatory milestones are press-worthy when they are framed against the workflow problem and the path to broader adoption, not as standalone clearance announcements.
Funding or partnership narrative: "Why a major health system led our Series X, and what that signals about how clinical AI gets bought now."
Why it works. Strategic backing from a health system or payer is a stronger narrative than a generalist VC round in this category, because the buyer is also the validator.
Common Pitfalls
Avoid these and you are already ahead of most of the field.
Pitching the product without the clinical evidence story.
Lead every press and creator brief with peer-reviewed validation, real-world deployment data, or a credible regulatory pathway. Capability claims alone rarely earn coverage in healthcare press, and they almost never close health-system deals.
Targeting only IT and informatics leaders, ignoring practicing clinicians.
Run a parallel track for the clinical audience: peer-clinician case studies, LinkedIn voices from practicing physicians, and physician-creator coverage that builds peer trust. Clinical buy-in is what unlocks the rollout decision, even when IT signs the contract.
Underplaying the regulatory and compliance posture in launch coverage.
Make HIPAA, HITRUST, FDA pathway (where relevant), and data-handling policies part of every press and creator brief. Buyers in this category actively read for those signals, and a missing answer is read as a red flag.
Leading press with capability instead of outcomes.
Every capability claim should travel with an outcome: time-to-diagnosis, length of stay, readmission rate, specialist parity, or a similar real-world endpoint. Outcomes data is what earns coverage in healthcare press and what buyers forward internally.
FAQ
Asked by founders, marketing leads, and operators in this vertical every week.
Book a free strategy call. We will walk through where you are in the regulatory and clinical arc, the publications and clinician voices we would prioritize, and how the engagement would look.
